Kuster, Pallone, Blunt Rochester, and Craig Lead Letter to Improve Access to Opioid Reversal Medications
May 21, 2024
May 21, 2024
WASHINGTON, May 21 -- Rep. Ann Kuster, D-New Hampshire, issued the following news release:
Congresswoman Annie Kuster (NH-02) sent a letter to the Government Accountability Office's (GAO) Comptroller General Gene Dodaro requesting a study on the accessibility and affordability of FDA-approved opioid overdose reversal agents, including naloxone and nalmefene. This letter was co-led by Energy and Commerce Health Subcommittee Ranking Member Frank Pallone (NJ-06), alongside Represe . . .
Congresswoman Annie Kuster (NH-02) sent a letter to the Government Accountability Office's (GAO) Comptroller General Gene Dodaro requesting a study on the accessibility and affordability of FDA-approved opioid overdose reversal agents, including naloxone and nalmefene. This letter was co-led by Energy and Commerce Health Subcommittee Ranking Member Frank Pallone (NJ-06), alongside Represe . . .